Efficacy and Safety of Canakinumab in Acute Gouty Arthritis Patients with Chronic Kidney Disease Stage Greater Than or Equal to 3: A Post-Hoc Analysis of 12-Week Data.

被引：0

作者：

Sunkureddi, P. ^{[1
]}

Toth, E. ^{[2
]}

Brown, J. P. ^{[3
,4
]}

Kivitz, A. ^{[5
]}

Stancati, A. ^{[6
]}

Richard, D. ^{[6
]}

Lheritier, K. ^{[6
]}

Moericke, R. ^{[7
]}

机构：

[1] Clear Lake Rheumatol, Nassau Bay, TX USA

[2] Flor Francis Hosp, Dept Rheumatol, Kistarcsa, Hungary

[3] CHU Quebec, Res Ctr, Quebec City, PQ, Canada

[4] Univ Laval, Quebec City, PQ, Canada

[5] Altoona Ctr Clin Res, Duncansville, PA USA

[6] Novartis Pharma AG, Basel, Switzerland

[7] Inst Pravent Med & Klin Forsch GbR, Magdeburg, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

175

引用

页码：S73 / S74

页数：2